Revolution Medicines (RVMD) stock news
Every headline mentioning Revolution Medicines from Yahoo Finance and Nasdaq over the last 30 days, each scored for sentiment and importance. Updated automatically through the trading day.
Headlines0last 7 days · 3 in 30 days
Sentiment, 30 days
1 positive1 neutral1 negative
Latest headlineWed 16 Sep, 14:33 UTCHealthcare
Latest RVMD headlines
Wednesday, 16 September 2026
Friday, 4 September 2026
Revolution Med (RVMD) Priced Rasonque at $39,800 per 30-Day Supply. Can Access Match the Clinical Breakthrough?
VBK, RVMD, CRDO, CASY: Large Outflows Detected at ETF
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Vanguard Small-Cap Growth ETF (Symbol: VBK) where we have detected an approximate $171.9 million dollar…